摘要
目的观察肺力咳合剂治疗小儿支气管炎的疗效。方法将110例支气管炎的患儿分为两组,对照组50例,根据具体情况给予针对性抗感染治疗;治疗组60例,在对照组治疗基础上加用肺力咳合剂。观察两组患儿临床症状、体征好转情况及用药期间的不良反应。结果治疗组临床症状改善时间(包括退烧时间、咳嗽咳痰消失时间、啰音消失时间、平均治愈时间)明显短于对照组,差异有统计学意义(P<0.05);治疗组总有效率高于对照组,差异有统计学意义(P<0.05)。结论肺力咳合剂辅助治疗小儿支气管炎安全有效,患儿依从性良好,值得临床推广应用。
Objective To evaluate the clinical effect of the Feilike Heji on child acute bronchitis. Methods 110 ca- ses diagnosed as acute bronchitis were divided into two groups: the control group accepted specific anti - infection therapy, and the experiment group accepted the Feilike Heji combined with conventional treatment. Patients'clinical syndrome, physical signs and adverse reaction during the treatment were documented. Results Clinical syndrome amelioration of the experiment group (including fever removing time, cough extinction time, rale extinction time and average curing time) was faster than the control group. The total effective rate was obviously higher than the control group, and the difference was statistical significant ( P 〈 O. 05 ). Conclusion Feilike Heji which was apt to being accepted by children patients was safe and effective in the child acute bronchitis as an adjunctive therapy. It was worth of being spread into application.
出处
《临床合理用药杂志》
2012年第24期65-66,共2页
Chinese Journal of Clinical Rational Drug Use